Lost interest in generic drug manufacturer's a while ago- the market is too competitive and too dependent on world governments' largesse.
- Forums
- ASX - By Stock
- RMD
- ResMed in Numbers - Highlights from its Q4 of FY2018
RMD
resmed inc
Add to My Watchlist
1.59%
!
$39.52

ResMed in Numbers - Highlights from its Q4 of FY2018, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$39.52 |
Change
0.620(1.59%) |
Mkt cap ! $23.04B |
Open | High | Low | Value | Volume |
$38.99 | $39.53 | $38.95 | $33.03M | 840.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 583 | $39.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$39.60 | 2046 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 583 | 39.390 |
1 | 1342 | 39.370 |
1 | 11 | 39.300 |
2 | 86 | 39.000 |
1 | 1000 | 38.990 |
Price($) | Vol. | No. |
---|---|---|
39.600 | 2046 | 3 |
39.630 | 583 | 2 |
39.750 | 125 | 2 |
39.790 | 133 | 1 |
39.800 | 63 | 1 |
Last trade - 16.10pm 17/07/2025 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |